Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Bangs Dentallaboratorium ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   4.1% 2.5% 1.2% 1.8% 1.4% 1.6% 14.1% 14.1%   Credit score (0-100)   51 63 81 70 77 73 16 16   Credit rating   BBB BBB A A A A BB BB   Credit limit (kDKK)   0.0 0.0 39.2 2.0 19.5 7.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,067 2,077 2,433 3,691 3,156 3,265 0.0 0.0   EBITDA   529 486 819 1,943 1,498 1,764 0.0 0.0   EBIT   310 300 743 1,879 1,326 1,637 0.0 0.0   Pre-tax profit (PTP)   300.4 300.5 751.2 1,903.3 1,360.7 1,689.2 0.0 0.0   Net earnings   233.2 234.4 586.3 1,484.2 1,061.4 1,318.2 0.0 0.0   Pre-tax profit without non-rec. items   300 300 751 1,903 1,361 1,689 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   157 86.1 260 562 546 419 0.0 0.0   Shareholders equity total   449 683 969 1,853 1,415 1,633 283 283   Interest-bearing liabilities   275 0.2 32.8 47.4 30.0 67.6 0.0 0.0   Balance sheet total (assets)   1,092 1,056 1,686 3,016 2,143 2,516 283 283   Net Debt   69.0 -209 -480 -271 -343 -722 -283 -283     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,067 2,077 2,433 3,691 3,156 3,265 0.0 0.0   Gross profit growth   6.6% 0.5% 17.1% 51.7% -14.5% 3.5% -100.0% 0.0%   Employees   3 3 3 3 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,092 1,056 1,686 3,016 2,143 2,516 283 283   Balance sheet change%   -0.4% -3.3% 59.6% 78.9% -28.9% 17.4% -88.8% 0.0%   Added value   528.9 485.9 819.4 1,942.6 1,389.8 1,764.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -438 -356 97 238 -189 -254 -419 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   15.0% 14.4% 30.5% 50.9% 42.0% 50.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   28.3% 28.2% 55.2% 81.3% 52.9% 72.7% 0.0% 0.0%   ROI %   42.7% 42.8% 89.8% 131.2% 81.1% 107.0% 0.0% 0.0%   ROE %   43.8% 41.4% 71.0% 105.2% 65.0% 86.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   41.1% 64.7% 57.5% 61.5% 66.0% 64.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   13.1% -43.0% -58.6% -14.0% -22.9% -40.9% 0.0% 0.0%   Gearing %   61.4% 0.0% 3.4% 2.6% 2.1% 4.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.7% 1.7% 33.2% 20.9% 13.0% 7.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.2 2.4 1.9 2.1 2.1 2.3 0.0 0.0   Current Ratio   1.3 2.5 1.9 2.1 2.2 2.4 0.0 0.0   Cash and cash equivalent   206.4 209.2 513.2 318.6 372.8 790.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   166.1 563.0 675.2 1,268.3 845.0 1,190.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   176 162 273 648 463 588 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   176 162 273 648 499 588 0 0   EBIT / employee   103 100 248 626 442 546 0 0   Net earnings / employee   78 78 195 495 354 439 0 0